Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Reduced Left Ventricular Ejection Fraction

NCT06313840 is registered in ClinicalTrials.gov with Zoll Medical Corporation as lead sponsor.

NCT NCT06313840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06313840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Reduced Left Ventricular Ejection Fraction
Lead sponsor
Zoll Medical Corporation
Phase
Observational
Overall status
Completed
Start date
August 21, 2023
Completion date
January 20, 2025
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep apnea, heart failure